H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Census population 429,954. Minnesota Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Minneapolis clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Minneapolis storefront.
Extracellular Matrix (ECM) Therapy in Minneapolis, MN for clinics & physicians. ECM therapy products provi… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 15.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Together those PLACES numbers are why a city of 250k–500k still needs separate PRP and CTP protocols. extracellular matrix therapy inventory is national; utilization is J6-local.
National Extracellular Matrix (ECM) Therapy notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Minneapolis we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 7.4% of adults in Minneapolis have diagnosed diabetes — 4.6 points below the U.S. 12% figure.
If you already buy extracellular matrix therapy elsewhere, use this page as a check: homologous-use language, current National Government Services (NGS) article IDs, and PLACES 7.4% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 7.4% of adults — 4.6 points below the U.S. 12% figure. Obesity is 28.6%; arthritis is 15.2%. That is place-level BRFSS modeling, not a clinic census and not a Minneapolis trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Minnesota compliance risk.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
Start with the CDC National Diabetes Statistics Report and America's Health Rankings diabetes measure (BRFSS). Minnesota Department of Health is the state public-health home. Those are the citable sources — not this page’s city name in a headline.
Ask for the IFU, the lot-traceability packet, and the National Government Services (NGS) article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Minneapolis fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Minneapolis, MN.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Minneapolis is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Minneapolis — 4.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Minnesota Part B wound biologics follow this contractor (siblings: IL, WI). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Minneapolis. Useful for joint-program math; still needs a diagnosis and privileging.
No Minneapolis storefront. Joe Bradley is an active practice owner. extracellular matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.